돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1437020생성일: 2026년 10월 27일

Piperazine → 8-Chloro-11-(piperazin-1-yl)-dibenzo[b,f][1,4]oxazepine

https://huagongshe.com/reaction/1437020

반응식

참여 물질

역할이름HCID투입량
반응물PiperazineHCID 4837—
반응물Methyl iodideHCID 6328—
반응물2-Chlorodibenz(b,f)-1,4-oxazepin-11(10H)-oneHCID 76619—
반응물Lawesson's reagentHCID 87949—
용매TolueneHCID 1140—
생성물8-Chloro-11-(piperazin-1-yl)-dibenzo[b,f][1,4]oxazepineHCID 1173852057%

반응 조건

온도130 °C

반응 단계

A mixture of 8-chloro-10H-dibenzo[b,f][1,4]oxazepin-11-one (189JO29C) (17 mg, 0.069 mmol) and 2,4-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulfide (16 mg, 0.040 mmol) in toluene (2 mL) was heated in capped tube using microwave assisted heating (130° C., 20 minutes). The reaction mixture was cooled to room temperature and MeI (18 μL, 0.29 mmol) was added and the resulting mixture was heated in capped tube using microwave assisted heating (120° C., 20 minutes). The mixture was concentrated and the residue was taken up in pyridine (2 mL) and piperazine (25 mg, 0.29 mmol) was added. The resulting mixture was heated in a capped tube at 130° C. over night then using microwave assisted heating (160° C., 30 minutes). The mixture was concentrated, diluted with EtOAc and washed with water. The organic phase was applied onto a SCX-2 ion exchange column. The column was washed with MeOH, and then the product was eluted with NH3 (7 N in MeOH) to give 9.0 mg (57%) of the title compound (189JO31). MS (ESI) 314 (MH+). Purity for MH+ (UV/MS) 92/100.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07622461B2
출처 데이터셋uspto-grants-2009_11
ORD IDord-bbf1d306e0e8406a82cfaa75ef292e48
출처 메모uspto-grants-2009_11